Welcome to our dedicated page for Integer Holdings news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Holdings stock.
Integer Holdings Corporation reports news as a medical device contract development and manufacturing organization serving cardio and vascular, neuromodulation, and cardiac rhythm management markets. Company updates commonly cover sales trends, organic growth, product-line performance, adjusted earnings measures, debt and leverage, and outlook commentary tied to customer programs and new product activity.
Integer news also includes governance and capital-allocation developments, including board composition, shareholder engagement, share repurchase authorization, investor conference participation, and broader strategy updates. The company’s public identity includes the Greatbatch Medical and Lake Region Medical brands and engineering and manufacturing work for medical device customers.
Integer Holdings (NYSE: ITGR) reported second quarter 2026 sales of $464 million, down 2.6% year over year, with organic sales lower by 1.5%. GAAP operating income from continuing operations was $34.5 million, down 41.8%, and GAAP income from continuing operations was $23.6 million, down 36.2%.
Non-GAAP adjusted operating income was $73.0 million, down 10.2%, while adjusted EBITDA was $94.9 million, down 4.1%. Adjusted net income was $54.7 million, essentially flat, and adjusted EPS increased 3.2% to $1.60. Total debt rose to $1.238 billion, resulting in a leverage ratio of 3.2x adjusted EBITDA.
According to Integer, an affiliate of KKR will acquire all outstanding shares in an all‑cash transaction valued at $5.7 billion enterprise value, with shareholders to receive $127 per share. In light of the pending transaction, Integer withdrew its financial outlook and canceled its scheduled earnings call.
Integer (NYSE: ITGR) agreed to be acquired by an affiliate of investment funds managed by KKR (NYSE: KKR) in an all-cash transaction valuing Integer at an enterprise value of approximately $5.7 billion. Integer stockholders are to receive $127 per share in cash, a premium of about 51.8% to the April 29, 2026 closing price and 28.8% to the 30-day VWAP as of July 31, 2026.
The Integer Board unanimously approved the merger, following a strategic review begun April 30, 2026, and recommends stockholders vote for it. Closing is expected by year-end, subject to stockholder and regulatory approvals, and is not subject to a financing contingency. KKR will fund the deal with equity from its managed funds and committed debt. After closing, Integer will become a private company and its shares will be delisted from the NYSE. Integer also withdrew its financial outlook and cancelled its August 6, 2026 earnings call due to the pending transaction.
Integer (NYSE:ITGR) will host a webcast conference call to discuss Q2 2026 financial results and business highlights on Thursday, Aug. 6, 2026 at 8 a.m. CT (9 a.m. ET).
The company will release its second quarter 2026 results earlier that day and provide live and replay access via phone and its investor relations website.
Integer (NYSE: ITGR) announced it will participate in the Truist Securities 2026 MedTech Conference on June 16, 2026. Executive leaders will join a fireside chat at 10:40 a.m. ET, with a live webcast and replay available on the company’s investor relations website.
Integer (NYSE: ITGR) announced that its Board has initiated a strategic review to evaluate a full range of options, including a sale, merger, or strategic business combination versus continued standalone execution.
The Board cited strong interest received, appointed Goldman Sachs & Co. LLC as financial advisor and Davis Polk & Wardwell LLP as legal advisor, and set no timeline or assurance that a transaction will occur.
Integer Holdings (NYSE:ITGR) reported Q1 2026 results: sales $440 million (+0.5%), organic sales +1.3%, GAAP income from continuing operations $17 million (+173%), and adjusted operating income $61 million (down 14%).
The Board initiated a strategic review to maximize stockholder value; 2026 outlook provided with GAAP and non-GAAP ranges and leverage guidance of 2.5x–3.5x.
Integer (NYSE: ITGR) will participate in the 2026 Bank of America Healthcare Conference, May 12-14, 2026, with a fireside chat on May 12 at 1:40 p.m. PT. A live webcast and replay will be available on Integer's Investor Relations News & Events page at investor.integer.net.
Integer (NYSE: ITGR) announced a planned board leadership transition. Independent Chair Pamela G. Bailey will not stand for re-election at the May 20, 2026 Annual Meeting. Following the meeting, the Board intends to appoint director Donald J. Spence as independent Chair.
Mr. Spence has served on the Board since 2016, chairs the Compensation & Organization Committee and sits on two other committees; Ms. Bailey thanked colleagues and endorsed the succession.
Integer (NYSE: ITGR) will webcast a conference call to discuss financial results and business highlights for the first quarter ended April 3, 2026. The call is scheduled for Thursday, April 30, 2026 at 8 a.m. CT (9 a.m. ET), following a news release of results earlier that day.
Dial-in numbers, Conference ID 3120125, webcast registration and an audio replay available for seven days will be provided via the company's Investor Relations website.
Integer (NYSE: ITGR) appointed James Flanagan and Aaron Kapito to its Board of Directors effective March 12, 2026, adding financial, governance and risk‑management expertise.
The appointments follow a cooperation agreement with Irenic Capital Management; two existing directors will not stand for re‑election at the annual meeting.